Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation |
| |
Authors: | Lin Shanshan Wu Min Xu Yang Xiong Wei Yi Zhigang Zhang Xiaonan Zhenghong Yuan |
| |
Institution: | Laboratory of Molecular Virology, Shanghai Medical College, Fudan University, Shanghai 200032, China. |
| |
Abstract: | In our previous paper, we reported that myeloid differential primary response protein (MyD88), a key adaptor in the signaling cascade of the innate immune response, inhibits hepatitis B virus (HBV) replication. The MyD88 activated nuclear factor-kappaB (NF-kappaB) signaling pathway and the intracellular upregulation of NF-kappaB signaling can induce an antiviral effect. Therefore, the association between the inhibition of HBV replication by MyD88 and NF-kappaB activation was investigated further. The results show that NF-kappaB activation was moderately increased after MyD88 expression. The strong activation of NF-kappaB by the IkappaB kinase complex IKKalpha/IKKbeta dramatically suppressed HBV replication; the MyD88 dominant negative mutant that abrogated NF-kappaB activity did not inhibit HBV replication. Furthermore, the IkappaBalpha dominant negative mutant restored the inhibition of HBV replication by MyD88. These results support a role for NF-kappaB activation in the inhibition of HBV replication and suggest a novel mechanism for the inhibition of HBV replication by MyD88 protein. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|